Related Experiment Video
Updated: Apr 18, 2026

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Eravacycline (TP-434) is active in vitro against biofilms formed by uropathogenic Escherichia coli
Trudy H Grossman1, William O'Brien2, Kathryn O Kerstein2
1Tetraphase Pharmaceuticals, Watertown, Massachusetts, USA tgrossman@tphase.com.
Abstract:
Eravacycline (formerly TP-434) was evaluated in vitro against pre-established biofilms formed by a uropathogenic Escherichia coli strain. Biofilms were eradicated by 0.5 μg/ml eravacycline, which was within 2-fold of the MIC for planktonic cells. In contrast, colistin and meropenem disrupted biofilms at 32 and 2 μg/ml, respectively, concentrations well above their respective MICs of 0.5 and 0.03 μg/ml. Gentamicin and levofloxacin eradicated biofilms at concentrations within 2-fold of their MICs.
Related Concept Videos
Antimicrobial Effectiveness
Inhibitors of Bacterial DNA Synthesis
Biofilms
Inhibitors of Bacterial Protein Synthesis
Urinary Tract Infection II: Pathophysiology
Mechanism of Antibiotic Resistance in MRSA

